{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:14:14Z","timestamp":1789823654284,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jpeds.2010.10.012","type":"journal-article","created":{"date-parts":[[2010,12,4]],"date-time":"2010-12-04T04:20:54Z","timestamp":1291436454000},"page":"644-649.e1","source":"Crossref","is-referenced-by-count":167,"title":["Infliximab for Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Retrospective Study"],"prefix":"10.1016","volume":"158","author":[{"given":"Mary Beth","family":"Son","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberlee","family":"Gauvreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Corinaldesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana H.","family":"Tremoulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia E.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Fulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Sundel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane W.","family":"Newburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2010.10.012_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2010.10.012_bib2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/archpedi.154.7.694","article-title":"Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease","volume":"154","author":"Han","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jpeds.2010.10.012_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/INF.0b013e31815922b5","article-title":"Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan","volume":"27","author":"Uehara","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2010.10.012_bib4","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/00006454-199812000-00009","article-title":"Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US\/Canadian Kawasaki Syndrome Study Group","volume":"17","author":"Burns","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2010.10.012_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpeds.2007.12.021","article-title":"Resistance to intravenous immunoglobulin in children with Kawasaki disease","volume":"153","author":"Tremoulet","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2010.10.012_bib6","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1542\/peds.2004-2182","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"114","author":"Newburger","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2010.10.012_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00431-003-1267-y","article-title":"Plasma exchange for refractory Kawasaki disease","volume":"163","author":"Imagawa","year":"2004","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jpeds.2010.10.012_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3349\/ymj.2002.43.4.527","article-title":"A case of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate","volume":"43","author":"Lee","year":"2002","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jpeds.2010.10.012_bib9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00006454-200106000-00022","article-title":"Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy","volume":"20","author":"Raman","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2010.10.012_bib10","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1542\/peds.105.6.e78","article-title":"Initial intravenous gammaglobulin treatment failure in Kawasaki disease","volume":"105","author":"Wallace","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2010.10.012_bib11","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2008.06.011","article-title":"Infliximab treatment of intravenous immunoglobulin-resistant kawasaki disease","volume":"153","author":"Burns","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2010.10.012_bib12","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpeds.2004.12.022","article-title":"Infliximab treatment for refractory Kawasaki syndrome","volume":"146","author":"Burns","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2010.10.012_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2008-0730","article-title":"Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006","volume":"124","author":"Son","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2010.10.012_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-3476(78)80601-5","article-title":"Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults","volume":"93","author":"Haycock","year":"1978","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2010.10.012_bib15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/CIRCULATIONAHA.107.690875","article-title":"Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements","volume":"116","author":"McCrindle","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2010.10.012_bib16","series-title":"Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease","year":"1984"},{"key":"10.1016\/j.jpeds.2010.10.012_bib17","first-page":"174","article-title":"Kawasaki disease presenting with hepatitis and prolonged fever: report of one case","volume":"44","author":"Chen","year":"2003","journal-title":"Acta Paediatr Taiwan"},{"key":"10.1016\/j.jpeds.2010.10.012_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/15513818509026899","article-title":"Hepatomegaly and splenomegaly in Kawasaki disease","volume":"4","author":"Ohshio","year":"1985","journal-title":"Pediatr Pathol"},{"key":"10.1016\/j.jpeds.2010.10.012_bib19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2165\/00044011-200626110-00008","article-title":"Onset of liver damage after a single administration of infliximab in a patient with refractory ulcerative colitis","volume":"26","author":"Ierardi","year":"2006","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jpeds.2010.10.012_bib20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.5694\/j.1326-5377.2007.tb01396.x","article-title":"Autoimmune hepatitis following infliximab therapy for ankylosing spondylitis","volume":"187","author":"Ozorio","year":"2007","journal-title":"Med J Aust"},{"key":"10.1016\/j.jpeds.2010.10.012_bib21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10067-005-0169-y","article-title":"Serious liver disease induced by infliximab","volume":"26","author":"Tobon","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jpeds.2010.10.012_bib22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ASN.0000114554.67106.28","article-title":"Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"15","author":"Booth","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jpeds.2010.10.012_bib23","article-title":"Infliximab therapy in pediatric Takayasu\u2019s arteritis: report of two cases","author":"Buonuomo","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jpeds.2010.10.012_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0090-1229(90)90166-N","article-title":"Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions","volume":"56","author":"Matsubara","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jpeds.2010.10.012_bib25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1203\/PDR.0b013e31819ed68d","article-title":"Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease","volume":"65","author":"Hirono","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jpeds.2010.10.012_bib26","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2010.10.012_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/ncprheum0949","article-title":"Mycobacterial disease in patients with rheumatic disease","volume":"4","author":"van Ingen","year":"2008","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.jpeds.2010.10.012_bib28","unstructured":"Information on tumor necrosis factor (TNF) blockers and black box warning. 2009. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm109340.htm. Accessed September 10, 2010."},{"key":"10.1016\/j.jpeds.2010.10.012_bib29","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/art.27511","article-title":"Malignancy in children and tumor necrosis factor-alpha blockers: forty-eight cases reported to the food and drug administration","volume":"62","author":"Diak","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpeds.2010.10.012_bib30","doi-asserted-by":"crossref","unstructured":"McCroskery P, Wallace CA, Lovell DJ, Stryker S, Chernyukhin N, Blosch C, et\u00a0al. Summary of worldwide pediatric malignancies reported after exposure to etanercept. Pediatr Rheumatol Online J;8:18.","DOI":"10.1186\/1546-0096-8-18"},{"key":"10.1016\/j.jpeds.2010.10.012_bib31","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jpeds.2010.10.012_bib32","first-page":"217","article-title":"Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin","volume":"139","author":"Moran","year":"2000","journal-title":"Am Heart J"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347610008796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347610008796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T13:06:22Z","timestamp":1636895182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347610008796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0022347610008796"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2010.10.012","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}